Mark Zitter is the Founder and Chair of the Zetema Project. He founded the Project in 2016 to help inform and energize the national healthcare conversation. He was the Chairman and Founder of Zitter Health Insights, a business intelligence firm that provides insights focused on optimizing patient access to pharmaceuticals to life science companies, specialty pharmacies, and managed healthcare organizations. In 2019, Zitter Health Insights was sold to MMIT, a product, solutions and advisory company that brings transparency to pharmacy and medical benefit information. Mark was co-founder and CEO of Vital Decisions, a telephone counseling company for patients with life-limiting illnesses, which was sold to MTS Partners (now Windrose Health Partners) in 2012.
Mark serves as healthcare advisor and facilitator for the California Health Reform Initiative. He also is on the advisory boards of Riverside Partners, a private equity firm, and the behavior change company Motimatic. He has authored four books and numerous articles on healthcare. Mr. Zitter founded the Society of Chief Medical Officers and has been an editorial advisor for Evidence-Based Oncology and Pharmaceutical Executive. He has produced and chaired many of the nation’s largest conferences on specialty pharmacy, quality improvement, disease management, and pharmacoeconomics. He was publisher of the first newsletters in outcomes management and pharmacoeconomics.
Mark holds an MBA from Stanford University and a BA from Wesleyan University. He has been an invited speaker at hundreds of meetings, and has been a guest lecturer at Stanford Graduate School of Business, Harvard School of Public Health, Yale Medical School, Haas Business School at UC Berkeley, and The Wharton School at the University of Pennsylvania. He is past Chairman of SFJAZZ and is on the Board of Governors of the Commonwealth Club of California, where he hosts healthcare programs and chairs a series on end-of-life issues.